1. Home
  2. YELP vs HROW Comparison

YELP vs HROW Comparison

Compare YELP & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yelp Inc.

YELP

Yelp Inc.

HOLD

Current Price

$27.31

Market Cap

2.1B

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$40.64

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YELP
HROW
Founded
2004
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
1.7B
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
YELP
HROW
Price
$27.31
$40.64
Analyst Decision
Hold
Strong Buy
Analyst Count
5
8
Target Price
$31.60
$68.86
AVG Volume (30 Days)
965.9K
579.2K
Earning Date
02-12-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
37.30
N/A
EPS
2.25
N/A
Revenue
$1,466,918,000.00
$250,042,000.00
Revenue This Year
$5.73
$38.57
Revenue Next Year
$2.81
$42.17
P/E Ratio
$12.19
N/A
Revenue Growth
5.34
47.83
52 Week Low
$26.96
$20.85
52 Week High
$41.72
$54.85

Technical Indicators

Market Signals
Indicator
YELP
HROW
Relative Strength Index (RSI) 32.85 31.23
Support Level $26.96 $44.55
Resistance Level $29.58 $44.05
Average True Range (ATR) 0.86 2.08
MACD -0.19 -0.96
Stochastic Oscillator 9.22 1.26

Price Performance

Historical Comparison
YELP
HROW

About YELP Yelp Inc.

Yelp Inc operates in the online content market based in the United States. It provides a web-based platform and mobile application to bridge the gap between businesses and consumers. The platform assists consumers through product reviews, tips, photos and videos thereby enabling them in making better buying decisions and posting their feedbacks. Its products and services includes Advertising Products and Business Page Products. In addition, it also lets the buyers directly transact with businesses directly through its platform. Yelp generates revenue mainly from the sale of advertising on its website and mobile app to businesses. The company generates majority of the revenue from United States.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: